31P-MR spectroscopic imaging in hypertensive heart disease

European Radiology

Volumn 16, Issue 8, 2006, Pages 1796-1802

  Heyne, Jens Peter ^a   Rzanny, R ^a   Hansch, A ^a   Leder, U ^a   Reichenbach, J R ^a   Kaiser, W A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

31P MR spectroscopy; Chemical shift imaging; High energy phosphates; Hypertensive heart disease; Myocardial fibrosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHOLIPID; PHOSPHORUS 31; DIAGNOSTIC AGENT; PHOSPHORUS;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DIASTOLE; ELECTROCARDIOGRAPHY; ENERGY METABOLISM; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; IMAGING SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTOLE; ARTIFACT; CASE CONTROL STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; STATISTICAL MODEL;

ADULT; ARTIFACTS; CASE-CONTROL STUDIES; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHORUS ISOTOPES; STATISTICS, NONPARAMETRIC;

EID: 33745815602     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0170-0     Document Type: Article

References (45)

1. Hennersdorf MG, Schannwell CM, Schwartzkopff B, Strauer BE (2003) Regression of left ventricular hypertrophy in hypertensive heart disease. Herz 28(8):764-778
2. Weber KT (2000) Targeting pathological remodeling: Concepts of cardio-protection and reparation. Circulation 102:1342-1345
3. Weber KT (2001) Cardioreparation in hypertensive heart disease. Hypertension 38:588-591
4. Bottomley PA (1994) MR spectroscopy of the human heart: The status and the challenges. Radiology 191:593-612
5. Neubauer S, Horn M, Pabst T, Harre K, Stromer H, Bertsch G, Sandstede J, Ertl G, Hahn D, Kochsiek K (1997) Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J Investig Med 45:453-462
6. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD (1985) The creatine kinase system in normal and diseased human myocardium. N Engl J Med 24;313(17):1050-1054
7. Swain JL, Sabina RL, Peyton RB, Jones RN, Wechsler AS, Holmes EW (1982) Derangements in myocardial purine and pyrimidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophy. Proc Natl Acad Sci USA 79(2):655-659
8. Spindler M, Niebler R, Remkes H, Horn M, Lanz T, Neubauer S (2002) Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism. Am J Physiol Heart Circ Physiol 283(2):H680-H687
9. Dzeja PP, Terzic A, Wieringa B (2004) Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice. Mol Cell Biochem 256-257(1-2):13-27
10. Miller DD, Walsh RA (1990-1991) In vivo phosphorus-31 NMR spectroscopy of abnormal myocardial high-energy phosphate metabolism during cardiac stress in hypertensive-hypertrophied non-human primates. Int J Card Imaging 6:57-70
11. Osbakken M, Douglas PS, Ivanics T, Zhang DN, Van Winkle T (1992) Creatinine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy. J Am Coll Cardiol 19:223-228
12. Zhang J, Duncker DJ, Ya X, Zhang Y, Pavek T, Wei H, Merkle H, Ugurbil K, From AH, Bache RJ (1995) Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study. Circulation 92:1274-1283
13. Krahe T, Schindler R, Neubauer S, Ertl G, Horn M, Lackner K (1993) 31P-cardio-MR-spectroscopy in myocardial insufficiency. Rofo 159:64-70
14. Krahe T, Schindler R, Neubauer S, Hillenbrand H, Lackner K, Boesiger P, McKinnon G, Landwehr P, Ertl G (1991) In vivo 31P-cardiac magnetic resonance spectroscopy: Methods and the first clinical results. Rofo 155:506-512
15. Schindler R, Krahe T, Neubauer S, Hillenbrand H, Entzeroth C, Horn M, Lackner K, Ertl G (1992) The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium. Rofo 157:452-457
16. Beer M (2004) Cardiac spectroscopy: Techniques, indications and clinical results. Eur Radiol 14(6):1034-1047
17. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96:2190-2196
18. Löffler R, Sauter R, Kolem H, Haase A, von Kienlin M (1998) Localized spectroscopy from anatomically matched compartments: Improved sensitivity and localization for cardiac 31 P MRS in humans. J Magn Reson 134:287-299
19. Perings SM, Schulze K, Decking U, Kelm M, Strauer BE (2000) Age-related decline of PCr/ATP-ratio in progressively hypertrophied hearts of spontaneously hypertensive rats. Heart Vessels 15(4):197-202
20. Okada M, Mitsunami K, Inubushi T, Kinoshita M (1998) Influence of aging or left ventricular hypertrophy on the human heart: Contents of phosphorus metabolites measured by 31P MRS. Magn Reson Med 39(5):772-782
21. Schocke MF, Metzler B, Wolf C, Steinboeck P, Kremser C, Pachinger O, Jaschke W, Lukas P (2003) Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). Magn Reson Imaging 21(5):553-559
22. Beer M, Seyfarth T, Sandstede J, Landschutz W, Lipke C, Kostler H, von Kienlin M, Harre K, Hahn D, Neubauer S (2002) Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40(7):1267-1274
23. Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, de Roos A (1999) Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99(17):2261-2267
24. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GA, Lackner K (1992) 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86:1810-1818
25. Conway MA, Bottomley PA, Ouwerkerk R, Radda GK, Rajagopalan B (1998) Mitral regurgitation. Impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatinine/ATP ratios in human. Circulation 97:1716-1723
26. Beer M, Spindler M, Sandstede J, Remmert H, Beer S, Kostler H, Hahn D (2004) Detection of myocardial infarctions by acquisition-weighted 31P-MR spectroscopy in humans. J Magn Reson Imaging 20:798-802
27. Auffermann W, Chew WM, Wolfe CL, Tavares NJ, Parmley WW, Semelka RC, Donnelly T, Chatterjee K, Higgins CB (1991) Normal and diffusely abnormal myocardium in humans: Functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging. Radiology 179(1):253-259
28. Hansch A, Rzanny R, Heyne JP, Leder U, Reichenbach JR, Kaiser WA (2005) Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging. Eur Radiol 15(2):319-323
29. de Roos A, Doornbos J, Luyten PR, Oosterwaal LJ, van der Wall EE, den Hollander JA (1992) Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: Assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging 2(6):711-719
30. Jung WI, Sieverding L, Breuer J, Hoess T, Widmaier S, Schmidt O, Bunse M, van Erckelens F, Apitz J, Lutz O, Dietze GJ (1998) 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97:2536-2542
31. Jung WI, Hoess T, Bunse M, Widmaier S, Sieverding L, Breuer J, Apitz J, Schmidt O, van Erckelens F, Dietze GJ, Lutz O (2000) Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. Circulation 28;101(12):E121
32. Schaefer S (1990) Clinical nuclear magnetic resonance spectroscopy: insight into metabolism. Am J Cardiol 26;66(14):45F-50F
33. Sakuma H, Takeda K, Tagami T, Nakagawa T, Okamoto S, Konishi T, Nakano T (1993) 31P MR spectroscopy in hypertrophic cardiomyopathy: Comparison with Tl-201 myocardial perfusion imaging. Am Heart J 125(5 Pt 1):1323-1328
34. Wasser JS, Guthrie SS, Chari M (1997) In vitro tolerance to anoxia and ischemia in isolated hearts from hypoxia sensitive and hypoxia tolerant turtles. Comp Biochem Physiol A Physiol 118:1359-1370
35. Pucar D, Dzeja PP, Bast P, Gumina RJ, Drahl C, Lim L, Juranic N, Macura S, Terzic A (2004) Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopy. Mol Cell Biochem 256-257(1-2):281-289
36. Thebault MT, Kervarec N, Pichon R, Nonnotte G, Le Gal Y (2003) Distribution and potential role of cytosolic water-soluble phosphodiesters in fish. Physiol Biochem Zool 76(4):553-565
37. Choy PC, Tran K, Hatch GM, Kroeger EA (1997) Phospholipid metabolism in the mammalian heart. Prog Lipid Res 36(2-3):85-101
38. Hatch GM (2004) Cell biology of cardiac mitochondrial phospholipids. Biochem Cell Biol 82(1):99-112
39. Mrnka L, Novakova O, Pelouch V, Novak F (1996) Phospholipid composition in the rat heart exposed to pressure overload from birth. Physiol Res 45(1):83-85
40. Burt CT, Ribolow H (1994) Glycerol phosphorylcholine (GPC) and serine ethanolamine phosphodiester (SEP): Evolutionary mirrored metabolites and their potential metabolic roles. Comp Biochem Physiol Biochem Mol Biol 108(1):11-20
41. Volpi E, Nazemi R, Fujita S (2004) Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care 7(4):405-410
42. Schunk K, Pitton M, Duber C, Kersjes W, Schadmand-Fischer S, Thelen M (1999) Dynamic phosphorus-31 magnetic resonance spectroscopy of the quadriceps muscle: Effects of age and sex on spectroscopic results. Invest Radiol 34(2):116-125
43. Hancock CR, Brault JJ, Wiseman RW, Terjung RL, Meyer RA (2005) 31P-NMR observation of free ADP during fatiguing, repetitive contractions of murine skeletal muscle lacking AK1. Am J Physiol Cell Physiol 288(6):C1298-C1304
44. Zhang J, Merkle H, Hendrich K, Garwood M, From AH, Ugurbil K, Bache RJ (1993) Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 92(2):993-1003
45. Ingwall JS, Weiss RG (2004) Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95(2):135-145